<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06828</article-id><article-id pub-id-type="doi">10.7554/eLife.06828</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology and Stem Cells</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title><italic>Cis</italic> and <italic>trans</italic> RET signaling control the survival and central projection growth of rapidly adapting mechanoreceptors</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-28783"><name><surname>Fleming</surname><given-names>Michael S</given-names></name><aff><institution content-type="dept">Department of Neuroscience, Perelman School of Medicine</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28784"><name><surname>Vysochan</surname><given-names>Anna</given-names></name><aff><institution content-type="dept">Department of Neuroscience, Perelman School of Medicine</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28785"><name><surname>Paixão</surname><given-names>Sόnia</given-names></name><aff><institution content-type="dept">Molecules - Signals - Development</institution>, <institution>Max Planck Institute of Neurobiology</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28786"><name><surname>Niu</surname><given-names>Jingwen</given-names></name><aff><institution content-type="dept">Department of Neuroscience, Perelman School of Medicine</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-6426"><name><surname>Klein</surname><given-names>Rüdiger</given-names></name><aff><institution content-type="dept">Molecules - Signals - Development</institution>, <institution>Max Planck Institute of Neurobiology</institution>, <addr-line><named-content content-type="city">Martinsried</named-content></addr-line>, <country>Germany</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-28787"><name><surname>Savitt</surname><given-names>Joseph M</given-names></name><aff><institution>Parkinson's Disease and Movement Disorder Center of Maryland</institution>, <addr-line><named-content content-type="city">Elkridge</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-18016"><name><surname>Luo</surname><given-names>Wenqin</given-names></name><aff><institution content-type="dept">Department of Neuroscience, Perelman School of Medicine</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country><email>luow@mail.med.upenn.edu</email></aff><xref ref-type="fn" rid="conf1"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1880"><name><surname>Shen</surname><given-names>Kang</given-names></name><role>Reviewing editor</role><aff><institution>Howard Hughes Medical Institute, Stanford University</institution>, <country>United States</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>04</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06828</elocation-id><supplementary-material><ext-link xlink:href="elife-06828-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>03</day><month>02</month><year>2015</year></date><date date-type="accepted"><day>01</day><month>04</month><year>2015</year></date></history><permissions><copyright-statement>© 2015, Fleming et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Fleming et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>RET can be activated in <italic>cis</italic> or <italic>trans</italic> by its co-receptors and ligands <italic>in vitro</italic>, but the physiological roles of <italic>trans</italic> signaling are unclear. Rapidly adapting (RA) mechanoreceptors in dorsal root ganglia (DRGs) express <italic>Ret</italic> and the co-receptor <italic>Gfrα2</italic> and depend on <italic>Ret</italic> for survival and central projection growth. Here, we show that <italic>Ret</italic> and <italic>Gfrα2</italic> null mice display comparable early central projection deficits, but <italic>Gfrα2</italic> null RA mechanoreceptors recover later. Loss of <italic>Gfrα1</italic>, the co-receptor implicated in activating RET <italic>in trans</italic>, causes no significant central projection or cell survival deficit, but <italic>Gfrα1;Gfrα2</italic> double nulls phenocopy <italic>Ret</italic> nulls. Finally, we demonstrate that GFRα1 produced by neighboring DRG neurons activates RET in RA mechanoreceptors. Taken together, our results suggest that <italic>trans</italic> and <italic>cis</italic> RET signaling could function in the same developmental process and that the availability of both forms of activation likely enhances but not diversifies outcomes of RET signaling.</p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author keywords</title><kwd>neurotrophins</kwd><kwd>RET signaling</kwd><kwd>DRG neuron development</kwd><kwd>cis and trans activation</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: Mice except GDNFlacZ line were raised in a barrier facility in Hill Pavilion, the618 University of Pennsylvania. All procedures were conducted according to animal protocols619 approved by Institutional Animal Care and Use Committee (IACUC) of the University of620 Pennsylvania and National Institutes of Health guidelines. GDNFlacZ mice were raised in621 accordance with the European Community Council Directive of November 24, 1986622 (86/609/EEC), and approved by the ethics.</p></fn></fn-group></back></article>